| Foley Clinic Corp | |
|
1613 N Mckenzie St Foley AL 36535-2247 | |
| (251) 949-3479 | |
| Not Available |
| Full Name | Foley Clinic Corp |
|---|---|
| Speciality | Family Medicine |
| Location | 1613 N Mckenzie St, Foley, Alabama |
| Authorized Official Name and Position | James P. Wright (VP PHYSICIAN BUSINESS SERVICES) |
| Authorized Official Contact | 6157781502 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Foley Clinic Corp 4000 Meridian Blvd Franklin TN 37067-6325 Ph: (615) 778-1502 | Foley Clinic Corp 1613 N Mckenzie St Foley AL 36535-2247 Ph: (251) 949-3479 |
| NPI Number | 1629027826 |
|---|---|
| Provider Enumeration Date | 05/08/2006 |
| Last Update Date | 02/02/2019 |
| Medicare PECOS PAC ID | 5193741759 |
|---|---|
| Medicare Enrollment ID | O20051021000930 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629027826 | NPI | - | NPPES |
| Provider Name | Patrick L Bosarge |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1912982141 PECOS PAC ID: 0941294938 Enrollment ID: I20040413000329 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Amy R Woods |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1598763757 PECOS PAC ID: 8628033560 Enrollment ID: I20041119000899 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Debra A Davis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417117953 PECOS PAC ID: 7810941366 Enrollment ID: I20050308000430 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | James D West |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1689614174 PECOS PAC ID: 5698721157 Enrollment ID: I20050329000265 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | William Walton Beazley |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1093769648 PECOS PAC ID: 5193763845 Enrollment ID: I20050421001583 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Juan Ronderos |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1407875016 PECOS PAC ID: 8628019437 Enrollment ID: I20050520000887 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Michael T Sanford |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1477530855 PECOS PAC ID: 3779497508 Enrollment ID: I20050613000282 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Nidal Morrar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952382038 PECOS PAC ID: 4981636875 Enrollment ID: I20050908001023 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Russell Proctor |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1962511790 PECOS PAC ID: 8022081215 Enrollment ID: I20051216000747 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Neelam Khan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1427021435 PECOS PAC ID: 0547274433 Enrollment ID: I20060131000119 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Carol P Motley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1003866112 PECOS PAC ID: 0345256731 Enrollment ID: I20060222000277 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Lisa M Pattison |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1649350026 PECOS PAC ID: 0547278962 Enrollment ID: I20060327000855 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Debra Hebert |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1255387916 PECOS PAC ID: 6901898790 Enrollment ID: I20080609000438 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Thomas L Hagood |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1114129855 PECOS PAC ID: 6608947320 Enrollment ID: I20080624000037 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Jeffrey Lee Caylor |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1730153271 PECOS PAC ID: 4385692599 Enrollment ID: I20080812000547 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Mikelle A Maddox |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770578726 PECOS PAC ID: 1254482078 Enrollment ID: I20090707000520 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Brian Sumrall |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1225126154 PECOS PAC ID: 3678626363 Enrollment ID: I20090728000564 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Lee E Eslava |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639125602 PECOS PAC ID: 3274689526 Enrollment ID: I20090929000076 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Victor S Taylor |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790724458 PECOS PAC ID: 2466586656 Enrollment ID: I20100810000231 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Eric S Cheung |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225015381 PECOS PAC ID: 5991760340 Enrollment ID: I20100811000376 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Michael P Houston |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1962516682 PECOS PAC ID: 5193625036 Enrollment ID: I20101015000048 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Barbara Obrien |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1821097304 PECOS PAC ID: 6204029986 Enrollment ID: I20101026001192 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Stephen Timothy Jackson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1790799211 PECOS PAC ID: 3577758952 Enrollment ID: I20101111000014 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | George C Graves |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1043248420 PECOS PAC ID: 7618068032 Enrollment ID: I20101208000839 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Nicole M Bodine |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780981159 PECOS PAC ID: 1850574120 Enrollment ID: I20110323000869 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Martha Eskridge |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942592308 PECOS PAC ID: 8325217482 Enrollment ID: I20110805000147 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Samantha H Simmons |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609140540 PECOS PAC ID: 2769644418 Enrollment ID: I20120425000848 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Mark D East |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1376508861 PECOS PAC ID: 6507933041 Enrollment ID: I20130402000375 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Lisa Ellen Field |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144665597 PECOS PAC ID: 6800035601 Enrollment ID: I20130626000369 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Lauren R Arredondo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457797458 PECOS PAC ID: 3476792219 Enrollment ID: I20130626000816 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Bruce L Lovins |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1538260724 PECOS PAC ID: 1456524636 Enrollment ID: I20130823000976 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Richard Craig Brown |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1235428772 PECOS PAC ID: 4981847886 Enrollment ID: I20130824000194 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | David Baird Hurley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285058735 PECOS PAC ID: 8729219795 Enrollment ID: I20140317001086 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Lateisha Briana Scott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215333752 PECOS PAC ID: 2860717873 Enrollment ID: I20150216001287 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Karianne Hamel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235537267 PECOS PAC ID: 2264758556 Enrollment ID: I20150304000678 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Denise N Thomas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821498239 PECOS PAC ID: 7719108448 Enrollment ID: I20150504002058 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Willis T Nichols |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1063722684 PECOS PAC ID: 8325287279 Enrollment ID: I20150610001102 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Janine Skipper |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336538149 PECOS PAC ID: 8022323229 Enrollment ID: I20150818003442 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Daniel Sherling |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568605319 PECOS PAC ID: 5193996361 Enrollment ID: I20160211001928 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Krista S Silverman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1497912471 PECOS PAC ID: 7719156140 Enrollment ID: I20160505000934 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Valerie Zieman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699211573 PECOS PAC ID: 9739464751 Enrollment ID: I20170314000335 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Stephanie S Christensen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972993194 PECOS PAC ID: 4284959313 Enrollment ID: I20170926001144 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Jerry Barton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124543798 PECOS PAC ID: 6305111618 Enrollment ID: I20171011003247 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Michael Hall |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871029991 PECOS PAC ID: 6103192281 Enrollment ID: I20171017001938 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Kathleen T. Shine |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1851373500 PECOS PAC ID: 6901809086 Enrollment ID: I20180205000036 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Gerad E Gray |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639598246 PECOS PAC ID: 6406176668 Enrollment ID: I20180205000906 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Kaci D Sims |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1275976557 PECOS PAC ID: 2961624150 Enrollment ID: I20180521002419 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Timothy Francis Mott |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1265403448 PECOS PAC ID: 4688858509 Enrollment ID: I20180622002698 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Tina G Higgins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396259768 PECOS PAC ID: 5193070571 Enrollment ID: I20180626003520 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Anthony Key |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295220382 PECOS PAC ID: 5294085288 Enrollment ID: I20180912003767 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Maranda Fleming Mccoy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558863480 PECOS PAC ID: 0840541595 Enrollment ID: I20180919003885 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Amanda K Smith |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1831328343 PECOS PAC ID: 1850548355 Enrollment ID: I20181203002794 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Harrison B Pearl |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1073956744 PECOS PAC ID: 5496043002 Enrollment ID: I20190104002918 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Tiffany Wilson Wade |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033677885 PECOS PAC ID: 6204179005 Enrollment ID: I20190517002317 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Jennifer Nicole Odom |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255761938 PECOS PAC ID: 4385970730 Enrollment ID: I20190724000320 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Nicole Frohlich Winberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699335356 PECOS PAC ID: 7214264829 Enrollment ID: I20190805003354 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Wendy Vix |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639738081 PECOS PAC ID: 2567799182 Enrollment ID: I20190805003470 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Eric Edward Roberts |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1982921748 PECOS PAC ID: 5294951570 Enrollment ID: I20190816002842 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Allison M Bolton |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1245544550 PECOS PAC ID: 6709025646 Enrollment ID: I20191004000461 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Ricky Phillip Leff |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1558380642 PECOS PAC ID: 1951439827 Enrollment ID: I20200128002905 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Kara Leigh Tooley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699396093 PECOS PAC ID: 6608207519 Enrollment ID: I20200508002763 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Dianne Louise Bunner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215204292 PECOS PAC ID: 8820227465 Enrollment ID: I20200518001310 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Lindsey Mccormick |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1194263202 PECOS PAC ID: 7517389273 Enrollment ID: I20200625001420 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Elizabeth Wilson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1083077507 PECOS PAC ID: 2365736477 Enrollment ID: I20200720000943 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Phillip Wayne Comalander |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376086553 PECOS PAC ID: 3577980689 Enrollment ID: I20200902003540 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Paige Marion Mclain |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770177545 PECOS PAC ID: 2264848142 Enrollment ID: I20210302001246 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Laurie Barton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619998259 PECOS PAC ID: 6002717147 Enrollment ID: I20210312002332 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Julieana Brzozowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922696541 PECOS PAC ID: 6305253071 Enrollment ID: I20210324001984 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Melissa Goldman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811598261 PECOS PAC ID: 2567871791 Enrollment ID: I20210429000979 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Michelle O Butler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831440023 PECOS PAC ID: 3577716299 Enrollment ID: I20210430000850 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Maggie Mae Wallace |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366098642 PECOS PAC ID: 9133458664 Enrollment ID: I20210514000719 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Marilyn C Forehand |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205400827 PECOS PAC ID: 1759781024 Enrollment ID: I20210609000683 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Carrie Gray |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1740690916 PECOS PAC ID: 4688984610 Enrollment ID: I20210630001205 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Yelizaveta Agayeva Hamrick |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528564424 PECOS PAC ID: 2567863343 Enrollment ID: I20210630002866 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Rachel Nicole Nygaard |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871263202 PECOS PAC ID: 5496143497 Enrollment ID: I20211025001532 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Craig C Oliver |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1831552538 PECOS PAC ID: 6507151800 Enrollment ID: I20211110001750 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Jennifer K Catalanotto |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437812468 PECOS PAC ID: 2567853427 Enrollment ID: I20220103001738 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Richard Tarver Webb |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1790125805 PECOS PAC ID: 7719203942 Enrollment ID: I20220204000693 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Candace Elaine Moody |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1609816172 PECOS PAC ID: 6800785072 Enrollment ID: I20220211001722 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Adam Coleman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700534054 PECOS PAC ID: 7214315399 Enrollment ID: I20220601002082 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Ashley Baggett Von Bergen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811631609 PECOS PAC ID: 7810378643 Enrollment ID: I20220725002630 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Leah Kristen Soley |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1144294760 PECOS PAC ID: 4284815630 Enrollment ID: I20220801001012 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | William Edward Motch |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1417410812 PECOS PAC ID: 6002290343 Enrollment ID: I20220906000124 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Timothy F Linder |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649207416 PECOS PAC ID: 2264538974 Enrollment ID: I20220913003570 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Danielle Elizabeth Clark |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598492738 PECOS PAC ID: 0143605758 Enrollment ID: I20220919001146 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Barbara A Jernigan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124440201 PECOS PAC ID: 6002285301 Enrollment ID: I20221208001097 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Caleb Whitehead |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1588292676 PECOS PAC ID: 3173996915 Enrollment ID: I20230227001736 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Ian Scott Gilson |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225028855 PECOS PAC ID: 1254479389 Enrollment ID: I20230322000543 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Justin Len Deavers |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1407206675 PECOS PAC ID: 9638463730 Enrollment ID: I20230615002531 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Michael Montgomery Marfice |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1457989725 PECOS PAC ID: 4183085616 Enrollment ID: I20230801001595 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Jeremy James Osborne |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1699302208 PECOS PAC ID: 8325461171 Enrollment ID: I20230811001193 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | James Davison Stallworth |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316622582 PECOS PAC ID: 4880056209 Enrollment ID: I20230817001127 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
| Provider Name | Billy Morales |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629386347 PECOS PAC ID: 0840433942 Enrollment ID: I20231002000329 |
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
News Archive
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
Nanoparticles are particles that are smaller than 100 nanometers. They are typically obtained from metals and, because of their tiny size, have unique properties that make them useful for biomedical applications.
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
› Verified 1 days ago
Gulf Coast Occupational Sports And Pain Medicine Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 222 S Alston St, Foley, AL 36535 Phone: 251-923-2050 Fax: 251-923-2051 | |
Gastroenterologists Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1625 N Alston St, Foley, AL 36535 Phone: 251-970-1954 Fax: 251-970-1960 | |
The Dimitri Clinic - Foley Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1506 N Mckenzie St, Suite 106, Foley, AL 36535 Phone: 985-643-4512 Fax: 985-643-4513 | |
Foley Family Practice Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 205 W Orange Ave, Foley, AL 36535 Phone: 251-943-6108 Fax: 251-943-6108 | |
South Baldwin Family Practice Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 202 W Orange Ave, Foley, AL 36535 Phone: 251-943-7237 Fax: 251-943-2451 | |
Alabama Medical Care, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1715 N Bunner St, Foley, AL 36535 Phone: 251-943-2300 Fax: 251-943-2416 | |
Centro Medico Familiar /family Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 106 W Rosetta Ave, Foley, AL 36535 Phone: 251-281-2966 |